Vertex Pharma's £1.65 million ($2.05 million) gene-editing therapy for sickle cell disease (SCD), Casgevy, has been given the green light for use by the NHS in England under a managed access ...

Acanthocyte Erythrocyte identified by numerous spiny cytoplasmic projections; similar to a Burr cell Acanthocytosis ... evaluated on a peripheral smear May be a normal variation in neonates.

Scientists have found a potential new gene variant target to treat sickle cell disease, an inherited blood disorder that affects about 300,000 people globally each year, with limited treatment options ...

People with megaloblastic anemia are more likely to have associated signs of vitamin deficiency that can be detected with a physical examination, such as peripheral ... your blood smear would show ...

Spherocytosis, otherwise known as hereditary spherocytosis, is an inherited blood disorder that causes red blood cells to become sphere-shaped (spherocytes) rather than their normal disk shape.